DIA EUROPE 2019

Patient engagement remains very much in vogue, but does it really make a difference? This session will look at why patient engagement matters to different stakeholders in the value chain of medicines. We will explore patient engagement strategies within various institutions, organisations and companies - and the kind of buy-in needed from different stakeholders (patient organisations, industry, regulators, policy makers, HCPs) involved in making patient engagement happen across the entire life cycle. We will look candidly at some of the challenges of patient engagement and if we are where we need to be as we move towards the next decade of the 21st century. • A Brief History – The roots of patient engagement • Key Pillars of the IMI Patient Engagement Strategy • Prioritising Patient Engagement at the EMA and Looking to the Future • Transforming a Major Pharma towards Patient Engagement